These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31573955)
1. Identification of FES as a Novel Radiosensitizing Target in Human Cancers. Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repair. Wei D; Parsels LA; Karnak D; Davis MA; Parsels JD; Marsh AC; Zhao L; Maybaum J; Lawrence TS; Sun Y; Morgan MA Clin Cancer Res; 2013 Aug; 19(16):4422-32. PubMed ID: 23780887 [TBL] [Abstract][Full Text] [Related]
3. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway. Lei Y; Li HX; Jin WS; Peng WR; Zhang CJ; Bu LJ; Du YY; Ma T; Sun GP Int J Radiat Biol; 2013 Dec; 89(12):1079-86. PubMed ID: 23875954 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase. Chung EJ; Brown AP; Asano H; Mandler M; Burgan WE; Carter D; Camphausen K; Citrin D Clin Cancer Res; 2009 May; 15(9):3050-7. PubMed ID: 19366835 [TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2. Cao C; Shinohara ET; Subhawong TK; Geng L; Kim KW; Albert JM; Hallahan DE; Lu B Mol Cancer Ther; 2006 Feb; 5(2):411-7. PubMed ID: 16505116 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor. Chow Z; Johnson J; Chauhan A; Jeong JC; Castle JT; Izumi T; Weiss H; Townsend CM; Schrader J; Anthony L; Yang ES; Evers BM; Rychahou P Cancer Lett; 2024 Aug; 596():216993. PubMed ID: 38801884 [TBL] [Abstract][Full Text] [Related]
7. PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells. Kim W; Youn H; Kwon T; Kang J; Kim E; Son B; Yang HJ; Jung Y; Youn B Pharmacol Res; 2013 Apr; 70(1):90-101. PubMed ID: 23352980 [TBL] [Abstract][Full Text] [Related]
8. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner. Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384 [TBL] [Abstract][Full Text] [Related]
9. Radiosensitization effect of quinoline-indole-schiff base derivative 10E on non-small cell lung cancer cells in vitro and in tumor xenografts. Liu H; Wang Q; Lan W; Liu D; Huang J; Yao J Invest New Drugs; 2024 Aug; 42(4):405-417. PubMed ID: 38880855 [TBL] [Abstract][Full Text] [Related]
10. Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects. Li B; Torossian A; Sun Y; Du R; Dicker AP; Lu B Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e525-31. PubMed ID: 22836051 [TBL] [Abstract][Full Text] [Related]
11. Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non-Small Cell Lung Cancers In Vitro and In Vivo. Tao Z; Le Blanc JM; Wang C; Zhan T; Zhuang H; Wang P; Yuan Z; Lu B Clin Cancer Res; 2016 Jan; 22(1):122-33. PubMed ID: 26728409 [TBL] [Abstract][Full Text] [Related]
12. Combined Aurora Kinase A and CHK1 Inhibition Enhances Radiosensitivity of Triple-Negative Breast Cancer Through Induction of Apoptosis and Mitotic Catastrophe Associated With Excessive DNA Damage. Li C; Liao J; Wang X; Chen FX; Guo X; Chen X Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1241-1254. PubMed ID: 37393021 [TBL] [Abstract][Full Text] [Related]
13. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition. Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596 [TBL] [Abstract][Full Text] [Related]
14. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells. Kanda S; Miyata Y; Kanetake H; Smithgall TE Int J Oncol; 2009 Jan; 34(1):89-96. PubMed ID: 19082481 [TBL] [Abstract][Full Text] [Related]
16. Murine double minute 2 as a therapeutic target for radiation sensitization of lung cancer. Cao C; Shinohara ET; Niermann KJ; Donnelly EF; Chen X; Hallahan DE; Lu B Mol Cancer Ther; 2005 Aug; 4(8):1137-45. PubMed ID: 16093429 [TBL] [Abstract][Full Text] [Related]
17. Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells. Wouters A; Pauwels B; Lambrechts HA; Pattyn GG; Ides J; Baay M; Meijnders P; Peeters M; Vermorken JB; Lardon F Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):558-66. PubMed ID: 21377279 [TBL] [Abstract][Full Text] [Related]
18. The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine. Ostruszka LJ; Shewach DS Cancer Res; 2000 Nov; 60(21):6080-8. PubMed ID: 11085531 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice. Carr MI; Roderick JE; Zhang H; Woda BA; Kelliher MA; Jones SN Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15024-15029. PubMed ID: 27956626 [TBL] [Abstract][Full Text] [Related]
20. Wang F; Xia X; Yang C; Shen J; Mai J; Kim HC; Kirui D; Kang Y; Fleming JB; Koay EJ; Mitra S; Ferrari M; Shen H Clin Cancer Res; 2018 Jul; 24(13):3176-3185. PubMed ID: 29602802 [No Abstract] [Full Text] [Related] [Next] [New Search]